The samples of this cohort were segregated into the following groups: IDH-wild-type (WT) gliomas, IDH-mutant + 1p/19q non-codel gliomas, and IDH-mutant + 1p/19q codel gliomas. The gene discussed is IDH1; the disease is central nervous system cancer.